Status:
COMPLETED
Cytokine Adsorption in Lung Transplantation
Lead Sponsor:
Lund University Hospital
Conditions:
Lung Transplant Failure
Lung Transplant; Complications
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Lung transplantation (LTx) remains the gold standard for treating patients with irreversible end-stage pulmonary disease. Of the major organs transplanted, survival in LTx recipients remains the lowes...
Detailed Description
Early intolerance to the newly transplanted lung starts at the time of transplantation and results in PGD driven by an intense inflammatory response. Cytokines play a critical role as signaling molecu...
Eligibility Criteria
Inclusion
- Double lung transplantation
- Single organ failure
Exclusion
- Re-transplantation
- Drug abuse
- Kidney failure
- Liver failure
- Diabetes mellitus
Key Trial Info
Start Date :
March 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05242289
Start Date
March 2 2022
End Date
August 30 2023
Last Update
September 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skåne University Hospital
Lund, Skåne County, Sweden, 224 60